KACIE CONDON: Open Payments
NPI 1942924907 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,748 in 262 payments from 19 companies in 2025. Trend: 2023 $7,143 · 2024 $7,480 · 2025 $8,748
Food & beverage: $5,589Consulting: $2,925Speaker / faculty: $133Education: $102
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 14 | $2,665 |
| ABBVIE INC. | 87 | $1,748 |
| Arcutis Biotherapeutics, Inc. | 13 | $1,000 |
| GENZYME CORPORATION | 13 | $763 |
| UCB, Inc. | 43 | $532 |
| Lilly USA, LLC | 13 | $336 |
| Novartis Pharmaceuticals Corporation | 12 | $282 |
| LEO Pharma Inc. | 10 | $243 |
| Regeneron Healthcare Solutions, Inc. | 7 | $199 |
| Amgen Inc. | 9 | $195 |
Products named: CIBINQO, SKYRIZI, DUPIXENT, Zoryve, RINVOQ, Bimzelx, OTEZLA, EBGLYSS.
Industry payments across CA — which companies pay providers there.
